# An Interesting Case of Anti-Small Ubiquitin-Like Modifier-Activating Enzyme (SAE) Antibody-Positive Dermatomyositis

## TL;DR

This paper discusses a rare case of dermatomyositis linked to anti-SAE antibodies, emphasizing the challenges in diagnosis and treatment.

## Contribution

The novelty lies in presenting a rare clinical case of anti-SAE-positive dermatomyositis with steroid resistance.

## Key findings

- Anti-SAE antibodies are associated with distinct cutaneous and systemic features in DM.
- Steroid-refractory cases of anti-SAE-positive DM pose significant therapeutic challenges.
- Early recognition and personalized treatment are crucial for managing this rare DM subtype.

## Abstract

Dermatomyositis (DM) is a heterogeneous autoimmune disease characterized by inflammatory involvement of the skin and muscles. Anti-small ubiquitin-like modifier activating enzyme (SAE) antibodies define a rare clinical subtype of DM, often associated with prominent cutaneous findings and systemic features such as dysphagia. This report presents the case of a 45-year-old male with steroid-refractory, anti-SAE-positive DM, highlighting the diagnostic and therapeutic challenges of this condition and underscoring the importance of early recognition and personalized management.